Q Synthesis LLC
  • Home
  • Systems Thinking
  • Implementation Science
  • About
  • Contact
  • Publications
  • Updates

Overcoming Barriers Around the Application of Immuno-Oncology

9/16/2019

0 Comments

 
This 1.5 hour online CME/CMLE multidisciplinary panel discussion will discuss how to apply the latest science and evidence as you navigate administrative challenges surrounding institutional policies and procedures. You will gain a deeper understanding that surrounds the complexity of PD-L1 testing based on the type of tumor, different antibody assays, and scoring systems. Additionally, you will learn about the practical application of MSI/MMR testing and the potentially emerging role of tumor mutational burden (TMB) when treating patients with checkpoint inhibitor therapy.

To claim CME credit for this course, please register at:
https://store.ascp.org/productlisting/productdetail?productId=104769493
0 Comments

Your comment will be posted after it is approved.


Leave a Reply.

    Author

    @DrJosephKim
    Joseph Kim, MD, MPH, MBA, FACEHP is the Founder and President of Q Synthesis LLC.

    ​View Dr. Kim's bio on LinkedIn. 

    ​


    Sign up to receive updates:
Q Synthesis LLC
www.qsynthesis.com
  • Home
  • Systems Thinking
  • Implementation Science
  • About
  • Contact
  • Publications
  • Updates